Canaccord downgraded Cree, Inc. CREE from Buy to Hold and lowered its price target from $41 to $29 in a report issued Wednesday.
Analyst Jonathan Dorsheimer commented that "in spite of the fact that we may be...marking the bottom for CREE shares, we simply fail to see a potentially positive catalyst to own the shares. Our thesis was based around the transition from captive to merchant sales in Cree’s components biz, which at best has been pushed by 6-9 months now."
The report noted that "Cree’s FQ2 guidance was well below Street and our expectations. Revenue estimates between $400M-$420M are well below the Street estimate of $452M and our previous $433M estimate."
"Our research confirms that CREE has lost market share in its components business to Lumileds combined with a shift to mid power in China. The combination is hitting GMs and sales abruptly," according to Dorsheimer.
Cree, Inc. recently traded at $28.09, down 15.26 percent.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.